(Q54079422)

English

Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

vascular disease

1 reference

based on heuristic

inferred from title

Factor V Leiden

1 reference

based on heuristic

inferred from title

author name string

Glueck CJ

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Wang P

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Fontaine RN

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Tracy T

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Sieve-Smith L

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Lang JE

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

84

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

549-554

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Marked Hyperlipidemia and Pancreatitis Associated with Oral Contraceptive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Arterial thromboembolic events in patients with the factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Factor V Leiden, prothrombin 20210 gene variant, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900375-6

7 January 2021

Identifiers

10.1016/S0002-9149(99)00375-6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10482153

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54079422&oldid=1542312664"